SCHEMBL17014841

SCHEMBL17014841

C#C[C@@]1(OC(=O)c2ccccc2)[C@H](OC(=O)c2ccccc2)C(CI)(N=[N+]=[N-])O[C@H]1n1ccc(=O)n(C(=O)c2ccccc2)c1=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15574758 1.00 — —
SCHEMBL17014842 0.87 — —
SCHEMBL15573388 0.87 — —
SCHEMBL15833186 0.86 POLB (0.33) —
SCHEMBL18430203 0.84 POLB (0.31) —
SCHEMBL15833192 0.82 POLB (0.33) —
SCHEMBL15837461 0.78 — —
SCHEMBL18408910 0.75 — —
SCHEMBL18408911 0.75 — —
SCHEMBL18430128 0.74 ABCC9 (0.31) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150232501-A1 2'-Ethynyl Nucleoside Derivatives for Treatment of Viral Infections NOVARTIS AG (CH) 2015-08-20 — — US disclosed
Send feedback